NovMetaPharma novmeta.com


NovMetaPharma (KONEX: 229500) is a pharmaceutical company focused on the development of new drugs for metabolic diseases. The company aims to introduce therapeutic agents for osteoporosis, non-alcoholic fatty liver disease, and immune system diseases.

NovMetaPharma (KONEX: 229500) is a pharmaceutical company focused on the development of new drugs for metabolic diseases. The company aims to introduce therapeutic agents for osteoporosis, non-alcoholic fatty liver disease, and immune system diseases...Show all

Company (IPO / Went public)

Phone: +82-2-538-1893

Fax:

13F Trees Building
727 Eonju-ro, Gangnam-gu
 Seoul, 06050
 South Korea

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
NovMetaPharma $0M Oct 1, 2015

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related NovMetaPharma Jobs

jobs by Indeed job search
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)